Blarcamesine/Donepezil Hydrochloride

N/A

Report date: 2022/09/06 14:06:19

Base Information

Drug NameBlarcamesine/Donepezil Hydrochloride
Drug Alias NameANAVEX 2-73/DPZANAVEX 2-73/donepezilDonepezil/ANAVEX 2-73Blarcamesine+Donepezil HydrochlorideDonepezil Hydrochloride/Blarcamesine +[6] 
ClassificationSmall molecules
Mechanisms of ActionImmunostimulantsAcetylcholinesterase inhibitorsMuscarinic acetylcholine receptor M1 agonists
TargetsAcetylcholinesteraseMuscarinic acetylcholine receptor M1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes BlarcamesineDonepezil Hydrochloride
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnavex Life Sciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesAnavex Life Sciences Corp
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A